Next Article in Journal
Mycobiome and Cancer: What Is the Evidence?
Next Article in Special Issue
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
Previous Article in Journal
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Previous Article in Special Issue
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
 
 
Review
Peer-Review Record

Integrative Analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence

Cancers 2021, 13(13), 3148; https://doi.org/10.3390/cancers13133148
by Youngjun Park 1, Dominik Heider 1 and Anne-Christin Hauschild 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Cancers 2021, 13(13), 3148; https://doi.org/10.3390/cancers13133148
Submission received: 20 May 2021 / Revised: 16 June 2021 / Accepted: 21 June 2021 / Published: 24 June 2021
(This article belongs to the Special Issue Next Generation Sequencing Application in Cancer Research)

Round 1

Reviewer 1 Report

The authors have organized the review well and the topic is current and of great interest. please correct the title of figure 1 (varaiety with variety). 

Author Response

Reviewer 1: Comments and Suggestions for Authors

The authors have organized the review well and the topic is current and of great interest. please correct the title of figure 1 (varaiety with variety).

- We thank the reviewer for pointing out this mistake. We corrected the typo in Figure 1 (Varaiety -> Variety). 

Reviewer 2 Report

The article is a concise review of applied AI . Although authors mention briefly AI  limitation in conclusion the article needs a dedicated paragraph/section on AI shortcoming.

Author Response

Reviewer 2: Comments and Suggestions for Authors
The article is a concise review of applied AI . Although authors mention briefly AI  limitation in conclusion the article needs a dedicated paragraph/section on AI shortcoming.

Reply: 
We thank the reviewer for the insightful suggestion. We added a dedicated paragraph in section 4.6 and changed the section title to include a description of the general shortcoming in AI and Deep Learning. We point out well-known limitations in AI, requiring large-scale data and interpretability.

Reviewer 3 Report

The manuscript of Park and Coworkers is well-written and nicely illustrated. It represents a comprehensive review of the issue, whose reading needs some knowledge of bio-informatics. I have a few comments for the authors.

1) Since the artificial intelligence is not the primary object of the review, a slightly different title might better reflect its content (e.g. Next-Generation Sequencing Data Integration for Next-Generation Cancer Research: Moving Toward Artificial Intelligence).

2) In the context of paragraph 1.2, the recent publication of Kotlov N et al. (Cancer Discovery 2021, 11, 1468-1489) might be usefully quoted.

3) Analogously, in the context of paragraph 2.2 the contribution of Langfelder P and Horvath S (WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9 559) should be quoted and discussed.

Author Response

Reviewer 3: Comments and Suggestions for Authors  

The manuscript of Park and Coworkers is well-written and nicely illustrated. It represents a comprehensive review of the issue, whose reading needs some knowledge of bio-informatics. I have a few comments for the authors.

1) Since the artificial intelligence is not the primary object of the review, a slightly different title might better reflect its content (e.g. Next-Generation Sequencing Data Integration for Next-Generation Cancer Research: Moving Toward Artificial Intelligence).

Reply: We thank the reviewer for the suggestion for the title. We changed the title to “Integrative analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence”


2) In the context of paragraph 1.2, the recent publication of Kotlov N et al. (Cancer Discovery 2021, 11, 1468-1489) might be usefully quoted.

Reply: We thank the reviewer for the suggestion. The study by Kotlov N et al. is a well-designed data integrative study. So it is well fitted in the tumor microenvironment section. We added the following sentences to section 1.2: “A recent large cohort study of lymphoma is showing the importance of a tumor microenvironment and its clinical importance. They identified novel microenvironments subtypes by defining 25 functional gene expression signatures reflecting pathway activities from transcriptome data.”

3) Analogously, in the context of paragraph 2.2 the contribution of Langfelder P and Horvath S (WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9 559) should be quoted and discussed.

Reply: We thank the reviewer for the suggestion. WGCNA is a landmark paper in de novo network construction study. We added the following sentence to section 2.2: “The WGCNA package implements a representative model using weighted correlation for network construction that leads the development of the network biology field.”

Back to TopTop